Skip to main content
Smart Investors Daily
UC

OTC · UCBJY

UCB S.A.

Healthcare · Biotechnology

$121.15

Down-$1.49 (-1.21%)

Updated Sep 28, 2026, 10:23 PM

SID Score

5.8/10

Composite research score

Smart Money

46/100

Neutral

Market cap
53.81B
P/E ratio
34.37
Dividend yield
0.65%
52-week range
— – —
Volume
6.26K
Avg. volume
29.22K

Price performance · UCBJY

UCBJY price history

1M range · 0 trading sessions · Daily adjusted prices

UCBJY does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest UCBJY news

The latest Smart Investors Daily articles mentioning UCBJY.

UCBJY research

Overview

Company profile and research snapshot.

Company profile

UCB SA UNSP/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
—
Implied upside
—
Analysts
9
UCBJY recent ratings
DateFirmRatingTarget
Sep 22, 2026TD COWENBuy—
Sep 21, 2026BERENBERGBuy—
Sep 17, 2026BAADER EUROPE / ALPHAVALUEBuy—
Sep 4, 2026JEFFERIESHold—
Sep 1, 2026DEGROOF PETERCAMBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 18, 2026

UCB (UCBJY) Upgraded to Buy: Here's Why

UCB (UCBJY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.